0001666071-24-000119.txt : 20240702
0001666071-24-000119.hdr.sgml : 20240702
20240702191205
ACCESSION NUMBER: 0001666071-24-000119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Amit
CENTRAL INDEX KEY: 0001961238
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 241097801
MAIL ADDRESS:
STREET 1: C/O CARDLYTICS, INC
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 4100
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wk-form4_1719961919.xml
FORM 4
X0508
4
2024-07-01
0
0001666071
Cardlytics, Inc.
CDLX
0001961238
Gupta Amit
675 PONCE DE LEON AVENUE NE
SUITE 4100
ATLANTA
GA
30308
0
1
0
0
Chief Operating Officer
0
Common Stock
2024-07-01
4
M
0
14349
A
137025
D
Common Stock
2024-07-02
4
S
0
7507
7.953
D
129518
D
Restricted Stock Units
2024-07-01
4
M
0
14349
0
D
Common Stock
14349
100447
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on July 1, 2024. The Reporting Person did not sell shares for any other purpose.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.85 to $8.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.
/s/ Nick Lynton, Attorney-in-Fact
2024-07-02